SAN RAFAEL, Calif.,
Feb. 8, 2017 /PRNewswire/
-- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today
announced that Jean-Jacques Bienaimé, Chairman and Chief Executive
Officer, will participate in the Leerink Partners 6th
Annual Global Healthcare Conference on February 16, 2017 at 1:00pm ET, in New York
City. Management will also participate in the Cowen and
Company 37th Annual Health Care Conference on
March 7, 2017 at 11:20am ET in Boston and the Barclays Global Healthcare
Conference on March 15, 2017 at
8:00am ET, in Miami. To access
the live webcasts, please visit the investor section of the
BioMarin website, www.biomarin.com. A replay will also be archived
on the site for at least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and
commercializes innovative therapies for people with serious and
life-threatening rare disorders. The company's portfolio consists
of five commercialized products and multiple clinical and
pre-clinical product candidates.
For additional information, please visit www.biomarin.com.
Information on BioMarin's website is not incorporated by reference
into this press release.
Contacts:
|
|
Investors
|
Media
|
Traci
McCarty
|
Debra
Charlesworth
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
(415)
455-7558
|
(415)
455-7451
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/biomarin-to-attend-three-investor-conferences-in-1q17-300402955.html
SOURCE BioMarin Pharmaceutical Inc.